Literature DB >> 28664933

Frequent homozygosity in both mature and immature ovarian teratomas: a shared genetic basis of tumorigenesis.

Olivia L Snir1, Maura DeJoseph2, Serena Wong1, Natalia Buza1, Pei Hui1.   

Abstract

Although homozygosity is well documented in mature teratomas, the genetic zygosity of ovarian immature teratomas and mixed germ cell tumors is less well studied. Ten cases of mature cystic teratomas, eleven cases of grade 2 or 3 immature teratomas, and seven cases of mixed germ cell tumors with an immature teratoma component were investigated by short tandem repeat genotyping to interrogate their genetic zygosity. DNA genotyping was informative in eight mature teratomas, seven immature teratomas and six cases of mixed germ cell tumors. Out of the eight mature teratomas, five cases showed partial or complete homozygosity (63%) with two cases demonstrating complete homozygosity (25%). Of the immature teratomas, six cases showed partial or complete homozygosity (86%) with two cases demonstrating complete homozygosity (29%). For the mixed germ cell tumors, two cases showed partial homozygosity (33%) and none displayed complete homozygosity. Long-term clinical follow-up was available for five immature teratomas (mean follow-up 110 months) and five mixed germ cell tumors (mean follow-up 66 months). None of the five patients with pure immature teratoma had a recurrence; in contrast, four out of five mixed ovarian germ cell tumors recurred between 4 months to 8 years (P=0.048). In conclusion, both immature and mature teratomas harbor frequent genetic homozygosity suggesting a common cellular origin involving germ cells at the same developmental stage. The difference in the rate of homozygosity and tumor recurrence between pure immature teratomas and mixed germ cell tumors suggests that the two entities may involve different pathogenetic pathways and likely pursue different biological behaviors.

Entities:  

Mesh:

Year:  2017        PMID: 28664933     DOI: 10.1038/modpathol.2017.66

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  23 in total

1.  Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division.

Authors:  J J Eppig; L P Kozak; E M Eicher; L C Stevens
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

2.  Incidence and survival rates for female malignant germ cell tumors.

Authors:  Harriet O Smith; Marianne Berwick; Claire F Verschraegen; Charles Wiggins; Letitia Lansing; Carolyn Y Muller; Clifford R Qualls
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

3.  DNA copy number changes in malignant ovarian germ cell tumors.

Authors:  S M Kraggerud; J Szymanska; V M Abeler; J Kaern; M Eknaes; S Heim; M R Teixeira; C G Tropé; P Peltomäki; R A Lothe
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

4.  Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases.

Authors:  S J Robboy; R E Scully
Journal:  Hum Pathol       Date:  1970-12       Impact factor: 3.466

5.  Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin.

Authors:  U Surti; L Hoffner; A Chakravarti; R E Ferrell
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

6.  Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group.

Authors:  S A Heifetz; B Cushing; R Giller; J J Shuster; C J Stolar; C D Vinocur; E P Hawkins
Journal:  Am J Surg Pathol       Date:  1998-09       Impact factor: 6.394

7.  Genetics and biology of human ovarian teratomas. III. Cytogenetics and origins of malignant ovarian germ cell tumors.

Authors:  L Hoffner; S Shen-Schwarz; R Deka; A Chakravarti; U Surti
Journal:  Cancer Genet Cytogenet       Date:  1992-08

8.  Analysis of ovarian teratomas for isochromosome 12p: evidence supporting a dual histogenetic pathway for teratomatous elements.

Authors:  Christopher Poulos; Liang Cheng; Shaobo Zhang; Deborah J Gersell; Thomas M Ulbright
Journal:  Mod Pathol       Date:  2006-06       Impact factor: 7.842

9.  Is gliomatosis peritonei derived from the associated ovarian teratoma?

Authors:  Man-Yee Kwan; Wouter Kalle; Gene T C Lau; John K C Chan
Journal:  Hum Pathol       Date:  2004-06       Impact factor: 3.466

10.  Benign ovarian teratomas. An analysis of their cellular origin.

Authors:  N Dahl; K H Gustavson; C Rune; I Gustavsson; U Pettersson
Journal:  Cancer Genet Cytogenet       Date:  1990-05
View more
  3 in total

1.  Genetic zygosity of mature ovarian teratomas, struma ovarii, and ovarian carcinoids.

Authors:  Noriko Kato; Kazuhiro Sakamoto; Koutaro Murakami; Yuri Iwasaki; Akihisa Kamataki; Akira Kurose
Journal:  Virchows Arch       Date:  2018-02-17       Impact factor: 4.064

2.  Ovarian Intermediate Trophoblastic Tumors: Genotyping Defines a Distinct Category of Nongestational Tumors of Germ Cell Type.

Authors:  Deyin Xing; Minghao Zhong; Fei Ye; Michael T O'Malley; Shaotiao Li; Russell Vang; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2020-04       Impact factor: 6.298

3.  A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.

Authors:  C Newton; K Murali; A Ahmad; H Hockings; R Graham; V Liberale; S-J Sarker; J Ledermann; D M Berney; J Shamash; S Banerjee; S Stoneham; M Lockley
Journal:  Eur J Cancer       Date:  2019-04-04       Impact factor: 9.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.